Databases Of The EGFR Variants And Target Drugs, A Mini Review

Sifen Lu, Yongzhao Zhou and Maoshan Chen
Additional contact information
Sifen Lu: Precision Medicine Center, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital of Sichuan University, No.37, Wuhou District National School Lane, Chengdu, Sichuan, China 610041
Yongzhao Zhou: Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, No. 37, Wuhou District National School Lane, Chengdu, Sichuan, China 610041
Maoshan Chen: Australian Centre for Blood Diseases, Department of Clinical Heamatology, Central Clinical School, Australia

Biomedical Journal of Scientific & Technical Research, 2019, vol. 18, issue 5, 13948-13952

Abstract: Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are highly promising drugs that are well tolerated and have good antitumor activity...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research; Annotation; EGFR TKI; NSCLC (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.003223.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.003223.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:18:y:2019:i:5:p:13948-13952

DOI: 10.26717/BJSTR.2019.18.003223

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().